Akira Hirasawa Selected Research

Tumor Biomarkers (Tumor Markers)

1/2020	Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance.
3/2005	[Diagnostic significance of tumor markers for gynecologic malignancies].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Hirasawa Research Topics

Disease

49	Neoplasms (Cancer) 01/2024 - 09/2002
19	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 03/2005
14	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 10/2002
7	Carcinoma (Carcinomatosis) 01/2023 - 01/2014
6	Insulin Resistance 01/2023 - 09/2011
5	Glomerulonephritis 01/2015 - 09/2004
4	Inflammation (Inflammations) 11/2023 - 02/2012
4	Obesity 01/2023 - 02/2012
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2018 - 09/2002
3	Disease Progression 01/2023 - 11/2017
3	Adenocarcinoma 06/2021 - 10/2007
3	Breast Neoplasms (Breast Cancer) 02/2021 - 05/2013
3	Endometrioid Carcinoma 01/2018 - 03/2011
3	Neoplasm Metastasis (Metastasis) 01/2017 - 06/2012
3	Carcinogenesis 10/2016 - 12/2006
3	Microsatellite Instability 09/2015 - 11/2009
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2015 - 11/2014
3	Ovarian Epithelial Carcinoma 01/2014 - 08/2010
2	Pain (Aches) 11/2023 - 01/2017
2	Hereditary Breast and Ovarian Cancer Syndrome 10/2021 - 05/2013
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 10/2016
2	Insulinoma 01/2020 - 01/2009
2	Metabolic Diseases (Metabolic Disease) 02/2018 - 01/2015
2	Endometrial Hyperplasia 01/2018 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 09/2011 - 01/2011
2	Starvation 05/2011 - 11/2004
2	Leukemia 01/2007 - 09/2003
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Periodontitis 11/2023
1	Gingivitis 11/2023
1	Carcinosarcoma 10/2023
1	Sepsis (Septicemia) 10/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023
1	Carcinoma in Situ 01/2022
1	Female Genital Diseases 01/2022
1	Neuroinflammatory Diseases 12/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 08/2023 - 08/2004
16	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 08/2023 - 11/2009
6	Fatty Acids (Saturated Fatty Acids)IBA 04/2020 - 05/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 11/2017
5	Antineoplastic Agents (Antineoplastics)IBA 08/2023 - 11/2002
4	Carboplatin (JM8)FDA LinkGeneric 10/2023 - 11/2017
4	Phosphotransferases (Kinase)IBA 07/2023 - 10/2011
4	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 05/2012
4	LigandsIBA 06/2012 - 01/2009
3	Immune Checkpoint InhibitorsIBA 10/2023 - 02/2020
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2023 - 03/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2011
3	Insulin (Novolin)FDA Link 01/2020 - 02/2012
3	IncretinsIBA 11/2019 - 01/2013
3	Hormones (Hormone)IBA 11/2019 - 01/2013
3	MicroRNAs (MicroRNA)IBA 01/2013 - 11/2010
2	TropomyosinIBA 07/2023 - 03/2020
2	Formaldehyde (Formol)FDA Link 05/2023 - 05/2021
2	ParaffinIBA 05/2023 - 05/2021
2	Messenger RNA (mRNA)IBA 01/2023 - 02/2018
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 09/2021
2	PlatinumIBA 04/2022 - 01/2020
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2021 - 09/2011
2	LipidsIBA 12/2021 - 02/2012
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 03/2005
2	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 04/2016
2	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2018 - 01/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017 - 01/2009
2	Indicators and Reagents (Reagents)IBA 01/2017 - 11/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 12/2013
2	Estrogens (Estrogen)FDA Link 09/2015 - 03/2011
2	Uridine Diphosphate (UDP)IBA 09/2015 - 12/2013
2	IsoenzymesIBA 01/2015 - 02/2009
2	RNA (Ribonucleic Acid)IBA 01/2013 - 02/2010
2	Casein Kinase II (Casein Kinase 2)IBA 10/2011 - 05/2005
2	Taxoids (Taxanes)IBA 10/2007 - 01/2007
2	GlucocorticoidsIBA 01/2007 - 09/2003
2	Complementary DNA (cDNA)IBA 09/2004 - 08/2002
1	SteroidsIBA 11/2023
1	PlasminogenIBA 11/2023
1	ChromatinIBA 08/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	CyclinsIBA 01/2023
1	pertuzumabIBA 01/2023
1	AfatinibIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 08/2022
1	taxaneIBA 04/2022
1	Bevacizumab (Avastin)FDA Link 02/2022
1	ProstaglandinsIBA 12/2021
1	Prostaglandin D2IBA 12/2021

Therapy/Procedure

18	Therapeutics 11/2023 - 10/2007
8	Drug Therapy (Chemotherapy) 10/2023 - 07/2010
8	Salpingo-oophorectomy 01/2022 - 05/2013
5	Genomic Medicine 01/2024 - 08/2021
4	Immunotherapy 10/2023 - 02/2020
4	Precision Medicine 09/2022 - 10/2021
4	Hysterectomy 01/2021 - 11/2012
3	Neoadjuvant Therapy 04/2022 - 11/2017
2	Lasers (Laser) 01/2022 - 01/2014
1	Homologous Transplantation 01/2024
1	Hematopoietic Stem Cell Transplantation 01/2024
1	Oral Hygiene (Dental Hygiene) 11/2023